Fact Sheet: President Donald J. Trump Announces Deal with Regeneron to Bring Most-Favored-Nation Pricing to American Patients Search Select Category All News Briefings & Statements All Presidential Actions Executive Orders Nominations & Appointments Presidential Memoranda Proclamations Fact Sheets Releases Remarks Research All Briefings & Statements Presidential Actions All Executive Orders Nominations & Appointments Presidential Memoranda Proclamations Fact Sheets Releases Remarks Research ADVANCING MOST-FAVORED-NATION (MFN) PRICING: Today, President Donald J. Trump announced the 17th agreement with a major pharmaceutical manufacturer, Regeneron, to lower prescription drug prices that Americans pay for some of the world’s most innovative drugs, in line with the lowest prices paid by other developed nations (known as the most-favored-nation, or MFN, price).…